165 related articles for article (PubMed ID: 30587936)
1. Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer.
Brett J; Boulton M; Watson E
Patient Prefer Adherence; 2018; 12():2639-2647. PubMed ID: 30587936
[TBL] [Abstract][Full Text] [Related]
2. Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial.
Graetz I; Hu X; Kocak M; Krukowski RA; Anderson JN; Waters TM; Curry AN; Robles A; Paladino A; Stepanski E; Vidal GA; Schwartzberg LS
JAMA Netw Open; 2024 Jun; 7(6):e2417873. PubMed ID: 38935379
[TBL] [Abstract][Full Text] [Related]
3. THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care.
Anderson JN; Krukowski RA; Paladino AJ; Graff JC; Schwartzberg L; Curry AN; Vidal GA; Jones TN; Waters TM; Graetz I
J Hosp Manag Health Policy; 2021 Mar; 5():. PubMed ID: 34308256
[TBL] [Abstract][Full Text] [Related]
4. THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.
Paladino AJ; Anderson JN; Krukowski RA; Waters T; Kocak M; Graff C; Blue R; Jones TN; Buzaglo J; Vidal G; Schwartzberg L; Graetz I
BMC Health Serv Res; 2019 Dec; 19(1):977. PubMed ID: 31856812
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.
Brett J; Boulton M; Fenlon D; Hulbert-Williams NJ; Walter FM; Donnelly P; Lavery BA; Morgan A; Morris C; Watson EK
Patient Prefer Adherence; 2018; 12():291-300. PubMed ID: 29497284
[TBL] [Abstract][Full Text] [Related]
6. The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.
Jacobs JM; Walsh EA; Park ER; Berger J; Peppercorn J; Partridge A; Horick N; Safren SA; Temel JS; Greer JA
Int J Behav Med; 2020 Dec; 27(6):687-697. PubMed ID: 32495240
[TBL] [Abstract][Full Text] [Related]
7. Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.
Green SMC; French DP; Graham CD; Hall LH; Rousseau N; Foy R; Clark J; Parbutt C; Raine E; Gardner B; Velikova G; Moore SJL; Buxton J; ; Smith SG
BMC Health Serv Res; 2022 Aug; 22(1):1081. PubMed ID: 36002831
[TBL] [Abstract][Full Text] [Related]
8. Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.
Stewart SF; Slodkowska-Barabasz J; McGeagh L; Moon Z; Brett J; Wells M; Brown MC; Turner M; Horne R; Fenlon D; Rehman F; Cain H; Donnelly P; Harmer V; Turner L; Rose J; Sharp L; Watson E;
Breast; 2023 Aug; 70():32-40. PubMed ID: 37300986
[TBL] [Abstract][Full Text] [Related]
9. Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.
Humphries B; Collins S; Guillaumie L; Lemieux J; Dionne A; Provencher L; Moisan J; Lauzier S
Pharmacy (Basel); 2018 Jun; 6(2):. PubMed ID: 29890738
[TBL] [Abstract][Full Text] [Related]
10. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379
[TBL] [Abstract][Full Text] [Related]
11. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
12. Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.
Toivonen KI; Oberoi D; King-Shier K; Piedalue KL; Rash JA; Carlson LE; Campbell TS
Curr Oncol; 2021 Jul; 28(4):2496-2515. PubMed ID: 34287250
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F
Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986
[TBL] [Abstract][Full Text] [Related]
14. Pilot randomized controlled trial of a program to enhance experience and adherence with adjuvant endocrine therapy among women with non-metastatic breast cancer: 12-month quantitative results.
Assan O; Memoli V; Guillaumie L; Turcotte V; Lemay M; Dionne A; Lemieux J; Provencher L; Gotay C; de Bruin M; Guénette L; Lauzier S
J Cancer Surviv; 2024 May; ():. PubMed ID: 38702555
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors.
Bright EE; Finkelstein LB; Nealis MS; Genung SR; Wrigley J; Gu HCJ; Schmiege SJ; Arch JJ
J Clin Oncol; 2023 Oct; 41(28):4548-4561. PubMed ID: 37531593
[TBL] [Abstract][Full Text] [Related]
16. A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer.
Toivonen KI; Carlson LE; Rash JA; Campbell TS
Patient Prefer Adherence; 2021; 15():2039-2050. PubMed ID: 34552322
[TBL] [Abstract][Full Text] [Related]
17. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
[TBL] [Abstract][Full Text] [Related]
18. Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study.
En-Nasery-de Heer S; Tromp VNMF; Westerman MJ; Konings I; Beckeringh JJ; Boons CLM; Timmers L; Hugtenburg JG
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13749. PubMed ID: 36300863
[TBL] [Abstract][Full Text] [Related]
19. The lived experience of breast cancer patients on adjuvant endocrine therapy: Side effects and coping strategies during the first year of medication initiation.
Gomaa S; Lopez A; Slamon R; Smith R; Telushi E; Lapitan E; Nightingale G; Miller S; Wen KY
Res Sq; 2023 Jan; ():. PubMed ID: 36778385
[TBL] [Abstract][Full Text] [Related]
20. Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach.
Janssen AM; Dam J; Prins J; Buffart LM; de Bruin M
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13721. PubMed ID: 36263723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]